Abstract
Objective The purpose of the study was to develop machine learning models using data from long-term care (LTC) insurance claims and care needs certifications to predict the individualized future care needs of each older adult.
Methods We collected LTC insurance-related data in the form of claims and care needs certification surveys from a municipality of Kanagawa Prefecture from 2009 to 2018. We used care needs certificate applications for model generation and the validation sample to build gradient boosting decision tree (GBDT) models to classify if 1) the insured’s care needs either remained stable or decreased or 2) the insured’s care needs increased after three years. The predictive model was trained and evaluated via k-fold cross-validation. The performance of the predictive model was observed in its accuracy, precision, recall, F1 score, area under the receiver-operator curve, and confusion matrix.
Results Long-term care certificate applications and claim data from 2009–2018 were associated with 92,239 insureds with a mean age of 86.1 years old at the time of application, of whom 67% were female. The classifications of increase in care needs after three years were predicted with AUC of 0.80.
Conclusions Machine learning is a valuable tool for predicting care needs increases in Japan’s LTC insurance system, which can be used to develop more targeted and efficient interventions to proactively reduce or prevent further functional deterioration, thereby helping older adults maintain a better quality of life.
Competing Interest Statement
HL, KF, MS, and KI report grants from Cabinet Office, Government of Japan, during the conduct of the study. SI and AT have nothing to disclose. HM is affiliated with the Department of Healthcare Quality Assessment at The University of Tokyo. The department is a social collaboration department supported by grants from National Clinical Database, Johnson & Johnson K.K., and Nipro Corporation.
Funding Statement
This study was supported by the Cross-Ministerial Strategic Innovation Promotion Program from the New Energy and Industrial Technology Development Organization, Japan.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of Japan Family Planning Association (ref No. 2018537).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated and analyzed during the current study are available the corresponding author on resonable request. Please contact the Ethics Committee, Japan Family Planning Association，Inc. (email:rinri-shinsa@jfpa.or.jp) and data owner Kanakawa prefecture MeByo labo (http://www.pref.kanagawa.jp/docs/bs5/cnt/f536534/index.html) for further information regarding the data availability of this study.
